The present innovation relates to a novel formulation capable of increasing the amount of stem cells and progenitor cells in circulation in the peripheral blood of a mammal; the formulation is characterized in that it contains defibrotide in combination with at least one haematopoietic factor having the capacity to mobilize haematopoietic progenitors, preferably G-CSF. The reducer receives the drive on a high side where each has the same rotational speed, and the reducer maintains a spooled cable on its low side, which rotates at reduced speed and increased torque. The quality of the article can be non-destructively diagnosed using a simple system. The actuator actuates the software production line to produce custom software products. The method also includes forming a recommendation set of recommendable items from the choice sets of recommendable items.